Cell BiologyDiabetesPeer-reviewed
Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant
Silvia Torchio, Gabriel Siracusano, Federica Cuozzo…·Lorenzo Piemonti
This study shows liraglutide treatment restores glucose-stimulated insulin secretion and reduces apoptosis in WFS1 mutant iPSC-derived β cells.